🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 12 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/11/2020 69,56 71,62 68,92 69,23 -0,47% 3,88% 881.000
11/11/2020 68,65 70,48 68,30 69,56 +1,28% 3,18% 726.500
10/11/2020 68,52 69,26 66,81 68,68 +0,85% 3,58% 938.200
09/11/2020 69,38 70,40 67,52 68,10 +2,48% 4,15% 1.237.900
06/11/2020 66,41 66,93 64,54 66,45 +0,73% 3,60% 578.700
05/11/2020 65,00 66,12 62,76 65,97 +2,53% 5,17% 1.026.300
04/11/2020 59,20 64,96 59,20 64,34 +8,19% 9,73% 1.369.600
03/11/2020 59,31 60,29 57,34 59,47 +2,15% 4,97% 948.800
02/11/2020 57,72 58,90 56,80 58,22 +1,61% 3,64% 968.400
30/10/2020 57,13 58,58 55,57 57,30 -1,36% 5,27% 1.039.400
29/10/2020 59,86 59,87 56,72 58,09 -2,24% 5,26% 1.046.900
28/10/2020 60,28 60,82 58,12 59,42 -3,68% 4,48% 1.173.000
27/10/2020 59,69 62,75 58,82 61,69 +4,38% 6,59% 1.401.100
26/10/2020 58,25 60,49 57,95 59,10 +0,37% 4,36% 1.533.800
23/10/2020 58,60 59,04 57,35 58,88 +0,55% 2,88% 1.351.100
22/10/2020 57,27 59,85 57,01 58,56 +3,24% 4,96% 1.667.400
21/10/2020 54,79 58,50 54,42 56,72 +3,62% 7,44% 2.048.300
20/10/2020 50,08 54,94 49,50 54,74 +9,31% 10,86% 1.872.900
19/10/2020 49,18 52,00 48,21 50,08 +1,42% 7,71% 1.655.500
16/10/2020 48,85 50,70 48,39 49,38 +1,08% 4,73% 1.202.900
15/10/2020 48,19 50,86 46,11 48,85 +9,87% 9,86% 4.025.600
14/10/2020 46,27 46,71 44,29 44,46 -4,43% 5,23% 806.300
13/10/2020 46,18 47,19 45,65 46,52 +0,28% 3,33% 645.200
12/10/2020 46,67 47,01 45,14 46,39 +0,74% 4,01% 690.700
09/10/2020 48,21 48,59 45,79 46,05 -4,08% 5,81% 992.800
08/10/2020 51,34 51,34 47,24 48,01 -0,19% 7,99% 1.896.500
07/10/2020 46,42 48,34 46,21 48,10 +3,65% 4,59% 528.300
06/10/2020 46,97 48,46 46,08 46,41 -1,50% 5,07% 877.500
05/10/2020 44,19 47,27 44,19 47,11 +7,51% 6,97% 1.121.800
02/10/2020 43,75 44,70 42,44 43,82 -2,10% 5,17% 1.004.800